ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SBFM Sunshine Biopharma Inc

1.64
-1.68 (-50.60%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sunshine Biopharma Inc SBFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.68 -50.60% 1.64 19:59:31
Open Price Low Price High Price Close Price Prev Close
2.34 1.73 2.45 1.765 3.32
more quote information »

Recent News

Date Time Source Heading
3/06/202416:05EDGAR2Form 8-K - Current report
3/05/202416:37EDGAR2Form PRE 14C - Other preliminary information statements
3/05/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202416:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202408:24EDGAR2Form PRE 14C - Other preliminary information statements
2/16/202417:01EDGAR2Form 8-K - Current report
2/15/202411:39EDGAR2Form 8-K - Current report
2/14/202415:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202411:18EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2/13/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202409:04EDGAR2Form 8-K - Current report
2/09/202417:17EDGAR2Form S-1/A - General form for registration of securities..
2/01/202416:17EDGAR2Form S-1 - General form for registration of securities under..
1/30/202412:38EDGAR2Form 8-K - Current report
1/08/202408:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/07/202316:59EDGAR2Form 8-K - Current report
12/04/202308:30GLOBESunshine Biopharma Moves Principal Office to New York City
11/13/202309:00EDGAR2Form 8-K - Current report
11/13/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202312:18EDGAR2Form 8-K - Current report
10/20/202313:06EDGAR2Form 8-K - Current report
10/19/202312:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/18/202313:32EDGAR2Form DEF 14A - Other definitive proxy statements
10/13/202310:44EDGAR2Form 8-K - Current report
9/05/202316:20EDGAR2Form DEF 14A - Other definitive proxy statements
8/25/202315:16EDGAR2Form PRE 14A - Other preliminary proxy statements
8/11/202309:00EDGAR2Form 8-K - Current report
8/11/202308:30GLOBESunshine Biopharma Reports 2023 Second Quarter Results:..
8/10/202317:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/16/202309:58GLOBESunshine Biopharma Announces Closing of $5.0 Million Private..
5/12/202308:00GLOBESunshine Biopharma Announces Pricing of $5.0 Million Private..
5/11/202309:00GLOBESunshine Biopharma Reports 2023 First Quarter..

Your Recent History

Delayed Upgrade Clock